Investor Martin Shkreli, popularly known as “Pharma Bro,” pushed back against criticism on this recent short position on iBuying platform Opendoor Technologies Inc. (NASDAQ: OPEN), which is rallying amid the Federal Reserve’s rate cuts on Wednesday.
Investor Martin Shkreli, popularly known as “Pharma Bro,” pushed back against criticism on this recent short position on iBuying platform Opendoor Technologies Inc. (NASDAQ: OPEN), which is rallying amid the Federal Reserve’s rate cuts on Wednesday.
Copyright © Louis Velazquez. All Rights Reserved.